HIF-1α, a critical regulator of cellular responses to hypoxia, is often overexpressed in cancer due to genetic alterations such as gain-of-function mutations in oncogenes such as the KRAS mutation and loss-of-function mutations in tumor suppressor genes. This evidence concerns the gene HIF1A and cancer.